{"nct_id":"NCT05457257","title":"Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2022-07-29","start_date_type":"ACTUAL","primary_completion_date":"2024-10-22","primary_completion_date_type":"ACTUAL","completion_date":"2025-09-30","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["AZN"]}